These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 836031)

  • 1. A kinetic investigation of subsites S1' and S2' in alpha-chymotrypsin and subtilisin BPN'.
    Morihara K; Oka T
    Arch Biochem Biophys; 1977 Jan; 178(1):188-94. PubMed ID: 836031
    [No Abstract]   [Full Text] [Related]  

  • 2. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide synthesis by proteases in organic solvents: medium effect on substrate specificity.
    Nagashima T; Watanabe A; Kise H
    Enzyme Microb Technol; 1992 Oct; 14(10):842-7. PubMed ID: 1368970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-substrate interactions in the hydrolysis of peptide substrates by thermitase, subtilisin BPN', and proteinase K.
    Brömme D; Peters K; Fink S; Fittkau S
    Arch Biochem Biophys; 1986 Feb; 244(2):439-46. PubMed ID: 3511847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of small peptide substrates parallels binding of chymotrypsin inhibitor 2 for mutants of subtilisin BPN'.
    Eder J; Rheinnecker M; Fersht AR
    FEBS Lett; 1993 Dec; 335(3):349-52. PubMed ID: 8262182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
    O'Sullivan DB; O'Connell TP; Mahon MM; Koenig A; Milne JJ; Fitzpatrick TB; Malthouse JP
    Biochemistry; 1999 May; 38(19):6187-94. PubMed ID: 10320347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of azapeptides with chymotrypsin-like enzymes. New inhibitors and active site titrants for chymotrypsin A alpha, subtilisin BPN', subtilisin Carlsberg, and human leukocyte cathepsin G.
    Gupton BF; Carroll DL; Tuhy PM; Kam CM; Powers JC
    J Biol Chem; 1984 Apr; 259(7):4279-87. PubMed ID: 6368557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin.
    Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC
    Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching.
    Grøn H; Meldal M; Breddam K
    Biochemistry; 1992 Jul; 31(26):6011-8. PubMed ID: 1627543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of N-benzoyl-L-tyrosine thiobenzyl ester as a protease substrate. Hydrolysis by alpha-chymotrypsin and subtilisin BPN.
    Farmer DA; Hageman JH
    J Biol Chem; 1975 Sep; 250(18):7366-71. PubMed ID: 240825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of the specificities of -chymotrypsin and subtilisin BPN'. Studies with flexible and 'locked' substrates.
    Pattabiraman TN; Lawson WB
    Biochem J; 1972 Feb; 126(3):659-65. PubMed ID: 5075272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of secondary interaction on the enzymatic activity of subtilisin BPN': comparison with alpha-chymotrypsin, trypsin, and elastase.
    Morihara K; Oka T
    FEBS Lett; 1973 Jun; 33(1):54-6. PubMed ID: 4737331
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the specificities of -chymotrypsin and subtilisin BPN'. Studies with flexible substrates.
    Pattabiraman TN; Lawson WB
    Biochem J; 1972 Feb; 126(3):645-57. PubMed ID: 5075271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.